Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
315 * !
|
Tue, 8/9/2022,
2:00 PM -
3:50 PM
|
CC-158AB
|
|
Statistical Innovation in Biomarker-Guided Clinical Development — Invited Papers
|
|
General Methodology
|
|
Organizer(s): Sammi Tang, Servier Pharmaceuticals
|
|
Chair(s): Jian Zhu, Servier Pharmaceuticals
|
|
2:05 PM
|
Optimize Patient Care with Machine Learning-Based Biomarkers
Jie Ding, Veracyte Inc.; Shuyang Wu, Veracyte Inc.; Jianghan Qu, Veracyte Inc.; Marla Johnson, Veracyte Inc.; Lori Lofaro, Veracyte Inc.; William Bulman, Veracyte Inc.; Sangeeta Bhorade, Veracyte Inc.; Sean Walsh, Veracyte Inc.; Jonathan Wilde, Veracyte Inc.; Giulia Kennedy, Veracyte Inc.; Jing Huang, Veracyte Inc.
|
|
2:30 PM
|
Bayesian Adaptive Alpha Allocation for Phase III Trials with Biomarker and Overall Population Objectives
Yue Shentu, Daiichi Sankyo Inc.; Cong Chen, Merck & Co., Inc.; Xuekui Zhang, University of Victoria
|
|
2:55 PM
|
Use of an Interactive Web Application to Support Exploratory Propensity Score Analyses: Experience from the Industry Perspective and Case Study
Elande Baro, Kite Pharma; Saran Vardhanabhuti, Kite Pharma; Jiali Yan, Kite Pharma; Qinghua Song, Kite Pharma
|
|
3:20 PM
|
An Improved Biomarker-Guided Adaptive Patient Enrichment Design
Zhaoyang Teng, Servier Pharmaceuticals; Sammi Tang, Servier Pharmaceuticals; Jian Zhu, Servier Pharmaceuticals; Zhenwei Zhou, Boston University
|
|
3:45 PM
|
Floor Discussion
|
Video Available to all JSM Registered Attendees. Please login to view.
|
